Document Detail

Parallel changes in neuronal AT1R and GRK5 expression following exercise training in heart failure.
MedLine Citation:
PMID:  22753221     Owner:  NLM     Status:  MEDLINE    
Although exercise training (ExT) is an important therapeutic strategy for improving quality of life in patients with chronic heart failure (CHF), the central mechanisms by which ExT is beneficial are not well understood. The angiotensin II type 1 receptor (AT1R) plays a pivotal role in the development of CHF and is upregulated in a number of tissues owing, in part, to transcription factor nuclear factor kappa B (NF-κB). In addition, AT1R is marked for internalization and recycling via G-protein-coupled receptor kinase (GRK) phosphorylation. Because previous studies have shown that the beneficial effects of ExT in CHF rely on a reduction in angiotensin II, we hypothesized ExT would decrease AT1R, GRK5, and NF-κB protein expression in the paraventricular nucleus and rostral ventrolateral medulla of CHF rats. Following infarction by coronary artery ligation, animals were exercised 4 weeks postsurgery on a treadmill at a final speed of 25 miles per minute for 60 minutes, 5 days per week for 6 weeks. Western blot analysis of paraventricular nucleus and rostral ventrolateral medulla micropunches revealed an upregulation of AT1R, GRK5, and NF-κB in the infarcted group that was reversed by ExT. Furthermore, the relative expression of phosphorylated AT1R and AT1R/GRK5 physical association was increased in the CHF sedentary group and reversed by ExT. Overexpression of GRK5 in cultured CATH.a neurons blunted angiotensin II-mediated upregulation of AT1R and NF-κB; conversely, silencing of GRK5 exacerbated angiotensin II-mediated AT1R and NF-κB upregulation. Taken together, increased GRK5 may regulate AT1R expression in CHF, and ExT mitigates AT1R and its pathway components.
Karla K V Haack; Christopher W Engler; Evlampia Papoutsi; Iraklis I Pipinos; Kaushik P Patel; Irving H Zucker
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural     Date:  2012-07-02
Journal Detail:
Title:  Hypertension     Volume:  60     ISSN:  1524-4563     ISO Abbreviation:  Hypertension     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-07-20     Completed Date:  2012-12-13     Revised Date:  2013-08-13    
Medline Journal Info:
Nlm Unique ID:  7906255     Medline TA:  Hypertension     Country:  United States    
Other Details:
Languages:  eng     Pagination:  354-61     Citation Subset:  IM    
Department of Cellular and Integrative Physiology, University of Nebraska Medical Center, 985850 Nebraska Medical Center, Omaha, NE 68198-5850, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angiotensin II / pharmacology
Cells, Cultured
Chronic Disease
Disease Models, Animal
G-Protein-Coupled Receptor Kinase 5 / metabolism*
Heart Failure / metabolism*,  physiopathology*
Medulla Oblongata / cytology,  metabolism
NF-kappa B / metabolism
Neurons / cytology,  metabolism*
Paraventricular Hypothalamic Nucleus / cytology,  metabolism
Physical Conditioning, Animal / physiology*
Rats, Sprague-Dawley
Receptor, Angiotensin, Type 1 / metabolism*
Up-Regulation / drug effects
Grant Support
Reg. No./Substance:
0/NF-kappa B; 0/Receptor, Angiotensin, Type 1; 11128-99-7/Angiotensin II; EC Receptor Kinase 5; EC protein, rat

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Pregnancy Outcome Following Exposure to Angiotensin-Converting Enzyme Inhibitors or Angiotensin Rece...
Next Document:  Relationship Between Short-Term Blood Pressure Variability and Large-Artery Stiffness in Human Hyper...